Patents by Inventor Patrick Van De Velde

Patrick Van De Velde has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treating menopause or perimenopause
    Patent number: 6011026
    Abstract: A method of treating menopause or perimenopause without estrogenic activity at the uterine level in women comprising administering to women an amount of a steroid of the formula ##STR1## wherein the substituents are defined as in the specification sufficient to treat menopause or perimenopause symptoms without estrogenic activity at the uterine level.
    Type: Grant
    Filed: February 12, 1999
    Date of Patent: January 4, 2000
    Assignee: Hoeschst Marion Roussel
    Inventors: Yamina Bouali, Daniel Philibert, Francois Nique, Jean-Georges Teutsch, Patrick Van De Velde
  • Method of treating menopause or perimenopause
    Patent number: 5981516
    Abstract: A method of treating cholesterol without estrogenic activity at the uterine level in women comprising administering to women an amount of a steroid of the formula ##STR1## wherein the substituents are defined as in the specification without estrogenic activity at the uterine level.
    Type: Grant
    Filed: December 18, 1997
    Date of Patent: November 9, 1999
    Assignee: Hoechst Marion Roussel
    Inventors: Yamina Bouali, Daniel Philibert, Francois Nique, Jean-Georges Teutsch, Patrick Van De Velde
  • 19-nor-steroids
    Patent number: 5707982
    Abstract: A 19-nor-steroid having a formula selected from the group consisting of ##STR1## wherein the A and B rings have a structure selected from the group consisting of ##STR2##
    Type: Grant
    Filed: May 28, 1993
    Date of Patent: January 13, 1998
    Assignee: ROUSSEL UCLAF
    Inventors: Andre Claussner, Daniel Philibert, Lucien Nedelec, Patrick Van De Velde, Francois Nique, Jean-Georges Teutsch
  • Anti-estrogenic activity of II.beta.-substituted-19-NOR Steroids
    Patent number: 5705494
    Abstract: Disclosed is a method of inducing anti-estrogenic activity in warm-blooded animals by the administration of a compound of the formula ##STR1## wherein the substituents are as defined in the specification.
    Type: Grant
    Filed: August 8, 1995
    Date of Patent: January 6, 1998
    Assignee: Roussel-Uclaf
    Inventors: Francois Nique, Jean-Georges Teutsch, Patrick Van de Velde
  • 11 beta-substituted-19 nor-steroids
    Patent number: 5679788
    Abstract: Intermediate compounds of a formula selected from the group consisting of ##STR1## which are useful intermediates for the preparation of final products of the formula ##STR2## wherein the substituents are defined in the specification.
    Type: Grant
    Filed: October 16, 1996
    Date of Patent: October 21, 1997
    Assignee: Roussel Uclaf
    Inventors: Francois Nique, Jean-Georges Teutsch, Patrick Van de Velde
  • 11-.beta. substituted-19-nor steroids
    Patent number: 5556845
    Abstract: A compound of the formula ##STR1## wherein the substituents are as defined in the specification.
    Type: Grant
    Filed: May 19, 1995
    Date of Patent: September 17, 1996
    Assignee: Roussel Uclaf
    Inventors: Fran.cedilla.ois Nique, Jean-Georges Teutsch, Patrick Van De Velde
  • 11-.beta. substituted-19-nor steroids
    Patent number: 5494907
    Abstract: A compound selected from the group consisting of a compound of the formula ##STR1## wherein the substituents are defined as in the specification having anti-estrogen activity.
    Type: Grant
    Filed: May 19, 1994
    Date of Patent: February 27, 1996
    Assignee: Roussel UCLAF
    Inventors: Francois Nique, Jean-Georges Teutsch, Patrick Van De Velde
  • 19-nor-steroids
    Patent number: 5290771
    Abstract: The novel compounds of the invention are 19 nor-steroids of the formula: ##STR1## Where A, B, C, D, X, Y, Z, R.sub.17, and R.sup.1 are as defined in the specification, having hormonal properties and their preparation and intermediates.
    Type: Grant
    Filed: April 29, 1992
    Date of Patent: March 1, 1994
    Assignee: Roussel Uclaf
    Inventors: Andre Claussner, Lucien Nedelec, Daniel Philibert, Patrick Van de Velde
  • 19.fwdarw.nor.fwdarw.steroids
    Patent number: 5149696
    Abstract: Novel 19-nor-steroids of the formula ##STR1## wherein the A and B rings have a structure selected from the group consisting of ##STR2## having hormonal properties and their preparation and intermediates.
    Type: Grant
    Filed: February 23, 1990
    Date of Patent: September 22, 1992
    Assignee: Roussel Uclaf
    Inventors: Andre Claussner, Lucien Nedelec, Daniel Philibert, Patrick Van De Velde